WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steven FrankDirector2026-05-291,262$8.91
$11.24kBuy
Vincent MilanoDirector2026-05-291,122$8.91
$10.00kBuy
Amy E. McKeeDirector2026-05-29631$8.91
$5.62kBuy
Jon P. StonehouseDirector2026-05-29631$8.91
$5.62kBuy
Jill C. MilneDirector2026-05-291,262$8.91
$11.24kBuy
Amy E. McKeeDirector2026-05-1811,180$8.97
$100.28kSell
Alane P. BarnesChief Legal Officer2026-05-1362,500$9.54
$596.25kSell
Alane P. BarnesChief Legal Officer2026-05-1362,500$5.04
$315.00kBuy
Theresa HeggieDirector2026-03-2049,933$10.11
$504.82kSell
Theresa HeggieDirector2026-03-2049,933$6.30
$314.58kBuy

1 of 5

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.91%22,650,988$197.06MInstitution
Baker Bros Advisors LP8.48%21,543,334$187.43MInsider
Ra Capital Management LP6.23%15,827,186$137.70MInstitution
Deerfield Management Company LP5.92%15,038,000$130.83MInstitution
State Street Corp4.80%12,208,360$106.21MInstitution
Vanguard Portfolio Management LLC4.42%11,244,625$97.83MInstitution
Vanguard Capital Management LLC4.38%11,135,762$96.88MInstitution
Tcg Crossover Management LLC4.34%11,020,968$95.88MInstitution
Janus Henderson Group PLC3.51%8,908,506$77.50MInstitution
Perceptive Advisors LLC2.92%7,434,033$64.68MInstitution

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX86.54%13.46%Net SellingNet Selling
VERA69.07%30.93%Net BuyingNet Selling
KOD73.18%26.82%Net BuyingNet Buying
RARE84.28%15.72%Net SellingNet Selling
NTLA73.66%26.34%Net Buying
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 97.38% institutional shareholders, 15.15% Biocryst Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 8.48% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $195.18M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.